Hypermutation and unique mutational signatures of occupational cholangiocarcinoma in printing workers exposed to haloalkanes

Carcinogenesis

Volumn 37, Issue 8, 2016, Pages 817-826

  Mimaki, Sachiyo ^a,b   Totsuka, Yukari ^c   Suzuki, Yutaka ^d   Nakai, Chikako ^a   Goto, Masanori ^c   Kojima, Motohiro ^a   Arakawa, Hirofumi ^b,c   Takemura, Shigekazu ^e   Tanaka, Shogo ^e   Marubashi, Shigeru ^f   Kinoshita, Masahiko ^e   Matsuda, Tomonari ^g   Shibata, Tatsuhiro ^c   Nakagama, Hitoshi ^c   Ochiai, Atsushi ^a   Kubo, Shoji ^e   Nakamori, Shoji ^h   Esumi, Hiroyasu ^a,i   Tsuchihara, Katsuya ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^g KYOTO UNIVERSITY   (Japan)

^h OSAKA NATIONAL HOSPITAL   (Japan)

ⁱ TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DICHLOROPROPANE; ALKANE DERIVATIVE; DICHLOROMETHANE; HALOALKANE DERIVATIVE; UNCLASSIFIED DRUG; PROPANE; PROPYLENE DICHLORIDE;

ADULT; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CANCER INCIDENCE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENOME ANALYSIS; HUMAN; JAPAN; MALE; NONHUMAN; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; PRINTING; PRIORITY JOURNAL; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SEQUENCE ANALYSIS; SOMATIC MUTATION; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; CHOLANGIOCARCINOMA; DRUG EFFECTS; EXOME; GENETICS; MUTATION; PATHOLOGY;

ADULT; CHOLANGIOCARCINOMA; EXOME; HUMANS; JAPAN; MALE; METHYLENE CHLORIDE; MUTATION; OCCUPATIONAL EXPOSURE; PRINTING; PROPANE; SALMONELLA TYPHIMURIUM;

EID: 84982893532     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgw066     Document Type: Article

References (49)

1. Matsuda, A. et al. (2014) Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J. Clin. Oncol., 44, 388-396.
2. Everhart, J.E. et al. (2009) Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology, 136, 1134-1144.
3. West, J. et al. (2006) Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br. J. Cancer, 94, 1751-1758.
4. Razumilava, N. et al. (2014) Cholangiocarcinoma. Lancet, 383, 2168-2179.
5. Khan, S.A. et al. (2005) Cholangiocarcinoma. Lancet, 366, 1303-1314.
6. Khan, S.A. et al. (2003) DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma. Gut, 52, 586-591.
7. Miyakawa, S. et al. (2009) Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J. Hepatobiliary Pancreat. Surg., 16, 1-7.
8. Kubo, S. et al. (2014) Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan. J. Hepatobiliary Pancreat. Sci., 21, 479-488.
9. Yamada, K. et al. (2014) Chemical exposure levels in printing workers with cholangiocarcinoma. J. Occup. Health, 56, 332-338.
10. Yamada, K. et al. (2015) Chemical exposure levels in printing workers with cholangiocarcinoma (second report). J. Occup. Health, 57, 245-252.
11. IARC. (2014) Perfluoro-octanoic acid, tetrafluoroethylene, dichloromethane, 1,2-dichloropropane, 1,3-propane sultone. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 110. IARC Working Group, Lyon.
12. Benbrahim-Tallaa, L. et al. (2014) Carcinogenicity of perfluorooctanoic acid, tetrafluoroethylene, dichloromethane, 1,2-dichloropropane, and 1,3-propane sultone. Lancet Oncol., 15, 924-925.
13. National Toxicology Program. (1986) NTP toxicology and carcinogen-esis studies of 1,2-dichloropropane (propylene dichloride) (CAS No. 78-87-5) in F344/N rats and B6C3F1 mice (Gavage Studies). Natl Toxicol. Program Tech. Rep. Ser., 263, 1-182.
14. Umeda, Y. et al. (2010) Inhalation carcinogenicity and toxicity of 1,2-dichloropropane in rats. Inhal. Toxicol., 22, 1116-1126.
15. National Toxicology Program. (1986) NTP toxicology and carcinogen-esis studies of dichloromethane (methylene chloride) (CAS No. 75-09-2) in F344/N rats and B6C3F1 mice (Inhalation Studies). Natl Toxicol. Program Tech. Rep. Ser., 306, 1-208.
16. Burek, J.D. et al. (1984) Methylene chloride: a two-year inhalation toxicity and oncogenicity study in rats and hamsters. Fundam. Appl. Toxicol., 4, 30-47.
17. DeMarini, D.M. et al. (1997) Glutathione S-transferase-mediated induction of GC->AT transitions by halomethanes in Salmonella. Environ. Mol. Mutagen., 30, 440-447.
18. Matsuda, T. et al. (2013) A pilot study for the mutation assay using a high-throughput DNA sequencer. Genes Environ, 35, 53-56.
19. Ojima, H. et al. (2010) Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate bio-marker for predicting the efficacy of gemcitabine treatment. Cancer Sci., 101, 882-888.
20. Wang, J.L. et al. (2001) An in vitro model for evaluation of vaporous toxicity of trichloroethylene and tetrachloroethylene to CHO-K1 cells. Chem. Biol. Interact., 137, 139-154.
21. Ong, C.K. et al. (2012) Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat. Genet., 44, 690-693.
22. Chan-On, W. et al. (2013) Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet., 45, 1474-1478.
23. Nakamura, H. et al. (2015) Genomic spectra of biliary tract cancer. Nat. Genet., 47, 1003-1010.
24. Timmermann, B. et al. (2010) Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis. PLoS One, 5, e15661.
25. Alexandrov, L.B. et al. (2013) Signatures of mutational processes in human cancer. Nature, 500, 415-421.
26. Pleasance, E.D. et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature, 463, 191-196.
27. Marsch, G.A. et al. (2001) Characterization of nucleoside and DNA adducts formed by S-(1-acetoxymethyl)glutathione and implications for dihalomethane-glutathione conjugates. Chem. Res. Toxicol., 14, 600-608.
28. Kumagai, S. et al. (2013) Cholangiocarcinoma among offset colour proof-printing workers exposed to 1,2-dichloropropane and/or dichloromethane. Occup. Environ. Med., 70, 508-510.
29. Suzuki, T. et al. (2014) Assessment of the genotoxicity of 1,2-dichloropropane and dichloromethane after individual and co-exposure by inhalation in mice. J. Occup. Health, 56, 205-214.
30. Kim, D.H. et al. (1990) Characterization of S-[2-(N1-adenyl)ethyl]glutathione as an adduct formed in RNA and DNA from 1,2-dibromoethane. Chem. Res. Toxicol., 3, 587-594.
31. Inskeep, P.B. et al. (1986) Covalent binding of 1,2-dihaloalkanes to DNA and stability of the major DNA adduct, S-[2-(N7-guanyl)ethyl]glutathione. Cancer Res., 46, 2839-2844.
32. Marsch, G.A. et al. (2004) Formation and mass spectrometric analysis of DNA and nucleoside adducts by S-(1-acetoxymethyl)glutathione and by glutathione S-transferase-mediated activation of dihalomethanes. Chem. Res. Toxicol., 17, 45-54.
33. Sherratt, P.J. et al. (2002) Direct comparison of the nature of mouse and human GST T1-1 and the implications on dichloromethane carcinogenicity. Toxicol. Appl. Pharmacol., 179, 89-97.
34. Graves, R.J. et al. (1996) DNA sequence analysis of methylene chloride-induced HPRT mutations in Chinese hamster ovary cells: comparison with the mutation spectrum obtained for 1,2-dibromoethane and formaldehyde. Mutagenesis, 11, 229-233.
35. Graves, R.J. et al. (1996) Mouse liver glutathione S-transferase mediated metabolism of methylene chloride to a mutagen in the CHO/HPRT assay. Mutat. Res., 367, 143-150.
36. Fichtinger-Schepman, A.M. et al. (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry, 24, 707-713.
37. Saris, C.P. et al. (1996) In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells. Carcinogenesis, 17, 2763-2769.
38. Woynarowski, J.M. et al. (1998) Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA. Mol. Pharmacol., 54, 770-777.
39. Lawley, P.D. et al. (1963) Further studies on the alkylation of nucleic acids and their constituent nucleotides. Biochem. J., 89, 127-138.
40. Beranek, D.T. (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res., 231, 11-30.
41. Lawley, P.D. et al. (1996) DNA adducts from chemotherapeutic agents. Mutat. Res., 355, 13-40.
42. Olivier, M. et al. (2014) Modelling mutational landscapes of human cancers in vitro. Sci. Rep., 4, 4482.
43. Honjo, T. et al. (2002) Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol., 20, 165-196.
44. Honjo, T. et al. (2004) AID: how does it aid antibody diversity? Immunity, 20, 659-668.
45. Okazaki, I.M. et al. (2003) Constitutive expression of AID leads to tumorigenesis. J. Exp. Med., 197, 1173-1181.
46. Kou, T. et al. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int. J. Cancer, 120, 469-476.
47. Matsumoto, Y. et al. (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med., 13, 470-476.
48. Komori, J. et al. (2008) Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology, 47, 888-896.
49. Trevisan, A. et al. (1993) In-vitro mechanisms of 1,2-dichloropropane nephrotoxicity using the renal cortical slice model. Hum. Exp. Toxicol., 12, 117-121.